Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skura was a prominent technology provider specializing in adaptive sales enablement and closed-loop marketing (CLM) for the life sciences and pharmaceutical sectors. The company's core offering, the Skura SFX platform, allowed pharmaceutical sales representatives to deliver interactive and personalized content to healthcare providers via mobile devices. This technology enabled real-time data collection on physician engagement, providing marketing teams with actionable insights to refine their messaging and strategy. Skura was widely recognized for its innovation in the digital detailing space and its ability to integrate with major CRM systems like Salesforce and Veeva. In June 2016, Skura was acquired by Indegene, a global healthcare solutions provider, to enhance its commercialization and digital transformation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skura.